SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending following a significant private exchange of convertible debt for common equity, a move aimed at strengthening the company's balance sheet at the expense of shareholder dilution. While some investors view the reduced debt load as a positive for future strategic flexibility, others are expressing frustration over the dilution, stagnant price action, and a perceived lack of clear communication from leadership regarding long-term growth initiatives.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is surging to a record-breaking $3 trillion market cap after an impressive earnings beat, driven by accelerating AWS growth and robust demand for AI infrastructure. The community is actively debating the company's massive capital expenditure plans, with bulls pointing to a significant backlog and long-term revenue potential as signs that the AI investment cycle is yielding tangible results.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending as investors rally behind Briumvi's strong commercial execution and the company's aggressive expansion into new indications like schizophrenia and myasthenia gravis, despite persistent short seller skepticism. The community is actively discussing the stock's long-term potential as a multi-billion dollar franchise and speculating on a potential buyout as it approaches key technical levels.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending as investors eagerly await Phase 3 IZAR-1 trial results, with community speculation intensified by the CEO's recent 'about a month' timeline and upcoming conference appearances. While sentiment remains bullish, the community is actively debating the timing of the readout and monitoring institutional activity, as the stock remains in a tight trading range while waiting for this critical clinical catalyst.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is trending as investors react to a flurry of positive catalysts, including recent collaboration announcements, ongoing international store expansion, and optimism surrounding the upcoming second-quarter earnings report. While the community is actively debating store productivity and the impact of the ongoing share repurchase program, many are focused on the stock's potential for a significant upside breakout as it continues to grow its market footprint.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is rebounding strongly as the broader AI infrastructure sector recovers from recent volatility driven by forced institutional liquidations and uncertainty surrounding hyperscaler capital expenditure. The community remains focused on CoreWeave's strategic Leidos partnership and its critical role in the accelerating long-term AI compute buildout, despite ongoing debates regarding its debt levels and high-growth execution risks.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is seeing strong momentum as investors rotate into hyperscalers following earnings reports that validated the ROI of aggressive AI infrastructure spending. The community is actively discussing whether this move marks a sustained breakout toward all-time highs or if investors should remain cautious and wait for a consolidation, given the rapid nature of the recent price expansion.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending as shareholders weigh the impact of its pending SkyWater Technology acquisition and ongoing broader sector rotation against concerns over share dilution and the company's reliance on M&A for revenue growth. Community discussion remains heavily polarized between long-term bulls highlighting quantum industry potential and government ties, and skeptical bears focused on the company's lack of organic revenue and the volatility surrounding the merger.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global Holdings Corp is experiencing heightened investor interest driven by anticipation of its upcoming earnings report, with the community actively debating whether the stock's strong relative strength and partnerships with major tech players will trigger a significant breakout. Investors are closely monitoring its progress toward GAAP profitability and the potential impact of strategic initiatives, while the stock continues to see volatility amid broader software sector sentiment.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is facing intense volatility as the market reacts to an upcoming FDA advisory committee meeting and potential regulatory decision regarding its cancer therapy, RP1. The community remains deeply divided, with discussions centered on conflicting interpretations of clinical data, the probability of a third complete response letter versus accelerated approval, and the stock's significant short interest potentially fueling rapid price swings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$HOWL objectively horrible update today. Long road ahead and TCE platform likely not worth much e.g. $bcaB. Can see this heading back to mid 0.30s.

Biotech Pharma Investor

Toadvine

$HOWL Lmao nothing &#39;objectively negative&#39; about it.  Neutral if anything.  You and your brother just love bashing each other&#39;s stocks....that&#39;s not the definition of &#39;objective analysis&#39;.  
 
Tell me what was negative in this PR ?  I&#39;ll be waiting.  A normal update that everyone expected.  Cash runway update and a blanket statement on &#39;strategic alternatives are continuing as planned&#39;.  Same update that every single other strat alt company does.  Not sure what you were expecting in this ER exactly...... the real value here is the news drop of asset/platform sales that will follow.  Especially since this ER was released 2 weeks earlier than ever before.

StockTwits Web

Werewolf Therapeutics Inc

BioAtla Inc

 objectively horrible update today. Long road ahead and TCE platform likely not worth much e.g. 

. Can see this heading back to mid 0.30s.

Brian Thomson

@SDBiotechInvestor At $.30, the market cap would be $525K. They just sold a pre clinical that was heavily better by the acquirer for $18.5M (in total). They have Phase III and other drugs and a robust platform.  No covenanted debt. About $20M or AP. They need to sell something, which is why they hired Tungsten. They haven&#39;t touched their SEPA since March. I don&#39;t know what will happen but I do think they should be able to get $45M for everything---and that would mean $10-15/sh, and also mean they sold everything at about $.10-.20 on the dollar in a very hot market.

 At $.30, the market cap would be $525K. They just sold a pre clinical that was heavily better by the acquirer for $18.5M (in total). They have Phase III and other drugs and a robust platform.  No covenanted debt. About $20M or AP. They need to sell something, which is why they hired Tungsten. They haven't touched their SEPA since March. I don't know what will happen but I do think they should be able to get $45M for everything---and that would mean $10-15/sh, and also mean they sold everything at about $.10-.20 on the dollar in a very hot market.